Patent ID: 11957754
Assignee: ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 15:
16. A method for treating a human subject in need of cellular therapy comprising
(a) reconstituting a population of cells with a solution comprising
(i) about 0.1-1.2 mM CaCl2, about 0.05-5 mM MgCl2, about 1-2.5 mM KCl, about 0.5-2 mM sodium citrate, about 15-17 mM dextrose, and about 125-175 mM NaCl, or
(ii) about 0.5-0.9 mM CaCl2, about 0.2-0.4 mM MgCl2, about 1.6-2.4 mM KCl, about 0.8-1.2 mM sodium citrate, about 13-19 mM dextrose, and about 116-174 mM NaCl, or
(iii) about 0.008-0.012% CaCl2 dihydrate, about 0.0048-0.0072% MgCl2 hexahydrate, about 0.012-0.018% KCl, about 0.028-0.042% sodium citrate dihydrate, about 0.23-0.35% dextrose, and about 0.68-1.02% NaCl, and

(b) administering an effective amount of the reconstituted population of cells to a subject in need thereof.